These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3228627)

  • 1. Platelet regeneration time: a statistical approach.
    Lopes AA; Maeda NY; Chamone DA; Sauaia N
    Braz J Med Biol Res; 1988; 21(3):471-3. PubMed ID: 3228627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
    Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
    Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a biochemical method for measuring platelet life-span.
    Stoltz JF; Voisin P
    Cell Biol Int Rep; 1979 Aug; 3(5):441-5. PubMed ID: 487454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activity (malondialdehyde production) after orthopaedic surgery: the effect of aspirin.
    Stulberg BN; Dorr LD; Ranawat CS; Weksler BB; Schneider R
    J Bone Joint Surg Am; 1981 Feb; 63(2):288-94. PubMed ID: 7462284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet malondialdehyde production kinetics after cyclooxygenase block. A study performed with a modified high sensitivity assay.
    Nenci GG; Parise P; Capodicasa E; Berrettini M
    Haemostasis; 1983; 13(1):53-60. PubMed ID: 6404715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 7. Malondialdehyde production and the release reaction in rat blood platelets: inhibition by aspirin and indomethacin ex vivo [proceedings].
    Gordon JL; MacIntyre DE; McMillan RM
    Br J Pharmacol; 1976 Oct; 58(2):299P-300P. PubMed ID: 974415
    [No Abstract]   [Full Text] [Related]  

  • 8. Malondialdehyde formation by blood platelets: a diagnostic test to assess acetylsalicylic acid induced thrombocytopathy?
    Hovinga JK; Felix R; Furlan M; Lämmle B
    Thromb Res; 1990 Jul; 59(1):89-95. PubMed ID: 2399531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
    Sullivan JM; Taylor JC; Samaha JK
    Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro.
    Livio M; Rajtar G; Merino J; de Gaetano G
    Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material.
    Violi F; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Lipids; 1985 May; 20(5):322-4. PubMed ID: 3925272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid-induced malondialdehyde formation in rat platelets. Kinetic aspects and inhibition by acetylsalicylic acid and indomethacin.
    de Gaetano G; Rajtar G; Livio M; Merino J
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):85-9. PubMed ID: 7393351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The recovery of platelet malondialdehyde production after a single intake of aspirin--the effect of dosage.
    Takayama H; Okuma M; Uchino H
    Thromb Haemost; 1982 Aug; 48(1):13-7. PubMed ID: 6813990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shear-induced platelet aggregation in aspirin-treated patients: initial experience with the novel PlaCor PRT device.
    Würtz M; Hvas AM; Wulff LN; Kristensen SD; Grove EL
    Thromb Res; 2012 Nov; 130(5):753-8. PubMed ID: 22995532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory diagnostic monitoring of individually dosed antithrombotic therapy with acetylsalicylic acid in patients with atherosclerosis].
    Misselwitz F; Norden C
    Z Med Lab Diagn; 1989; 30(1):43-4. PubMed ID: 2718577
    [No Abstract]   [Full Text] [Related]  

  • 16. Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation.
    Torsellini A; Doni L; Palinski W; Guidi G; Lombardi V
    Thromb Haemost; 1984 Aug; 52(1):4-6. PubMed ID: 6238444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formation of platelet malondialdehyde in hypertensive patients subjected to cycloergometric exercise tests].
    Davì G; Novo S; Riolo F; Pinto A; Mendola G; Mazzola A; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(10):1167-72. PubMed ID: 7326120
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
    Pönicke K; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S459-62. PubMed ID: 6440558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet malonyldialdehyde formation: an indicator of platelet hyperfunction.
    Stuart MJ
    Thromb Haemost; 1979 Aug; 42(2):649-54. PubMed ID: 505371
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of temperature and preservation time on the aggregation and MDA level of blood platelets].
    Stachecki B; Kaszkowiak M; Kotelba-Witkowska B; Jakuboszczak E; Fenrych W
    Acta Haematol Pol; 1986; 17(3-4):122-30. PubMed ID: 3591238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.